ML 3000 reduces gastric prostaglandin synthesis without causing mucosal injury
Authors:
- 1 December 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 271 (2-3) , 525-531
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- (6,7-Diaryldihydropyrrolizin-5-yl)acetic Acids, a Novel Class of Potent Dual Inhibitors of Both Cyclooxygenase and 5-LipoxygenaseJournal of Medicinal Chemistry, 1994
- Characterization of a simple animal model for nonsteroidal anti-inflammatory drug induced antral ulcerCanadian Journal of Physiology and Pharmacology, 1993
- Gastric ulceration: critical events at the neutrophil–endothelium interfaceCanadian Journal of Physiology and Pharmacology, 1993
- Nonessential role of leukotrienes as mediators of acute gastric mucosal injury induced by aspirin in ratsDigestive Diseases and Sciences, 1992
- Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylateGastroenterology, 1992
- Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathyInflammation, 1992
- Adaptation in the Pharmaceutical Industry, with Particular Reference to Gastrointestinal Drugs and DiseasesScandinavian Journal of Gastroenterology, 1992
- Role of leukotriene C4 in mucosal damage caused by necrotizing agents and indomethacin in the rat stomachGastroenterology, 1991
- The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in miceInflammation Research, 1987
- Role of prostanoids in the protective actions of BW755C on the gastric mucosaEuropean Journal of Pharmacology, 1985